INTRODUCTION
The human immunodeficiency virus (HIV) infection is associated with the progressive deterioration in cell immunity that culminates in acquired immunodeficiency syndrome (AIDS). The decline in cell immunity explains two complications in patients with AIDS: infections and neoplasia 2 .
Kaposi's sarcoma (KS), Non-Hodgkin lymphoma (NHL) and carcinoma of the uterine cervix are the most frequent neoplasms in AIDS patients. These are considered to be defining diseases for AIDS 6, 10, 16, 18 . According to some authors, other types of neoplasia also seem to be more common among HIV-positive individuals. Among these types are: squamous cell carcinoma of the head/neck and anal region, plasmacytoma, melanoma, small cell lung cancer, basal cell carcinoma, Hodgkin's lymphoma (HL) and germinative tumors 5, 9, 11, 13, 30, 34 . The neoplasms associated with AIDS occur more frequently in developed rather than in underdeveloped countries 12, 23 . LUCAS et al. 26 described seven cases of B-cell NHL (2.8%) among 247 necropsies on HIV-positive patients in Africa and commented that the rarity of this tumor in this continent is associated with the short survival rate of African patients.
Antiretroviral therapy has given rise to changes in the morbidity and mortality rates among HIV patients. In addition to reducing the occurrence of opportunistic infections, it has also affected the occurrence of neoplasms that are correlated with AIDS 20, 24, 28 . Some studies have shown decreases in KS and primary NHL of the central nervous system (CNS) and less significant decreases in systemic NHL 17 . On the other hand, other studies have not demonstrated any change in the frequency of KS, and slight increases in the frequencies of NHL, HL and different types of carcinoma 4, 5, 20, 24, 28 . The occurrence of neoplasia of the uterine cervix has not undergone any significant change since the use of highly active antiretroviral therapy 8, 15 .
Studies with large numbers of necropsies on AIDS patients in the literature have described overall findings relating to infections and neoplasms, giving greater emphasis to infections and malignant tumors. The frequency of malignant neoplasms is generally less than 20% 1, 20, 21, 24, 31, 33, 35 . In Brazil, there are two reports on the frequency of malignant neoplasia in autopsied AIDS patients: BORGES et al. 7 found five (9.6%) cases in 52 necropsies and CURY et al. 12 identified three (3.3%) in 92 necropsies. However, we didn't find works describing benign neoplasms in necropsies of patients with HIV infection.
We decided therefore, to evaluate the necropsies of HIV positive patients performed in a teaching hospital in Brazil between 1989 and MICHELETTI, A.R.; MACEDO, A.C.S.; BARBOSA E SILVA, G.; SILVA, A.C.A.L.; SILVA-VERGARA, M.L.; MURTA, E. 2008 (261 consecutive cases), describing all benign and malignant neoplasms, in an attempt to evaluate the prevalence of malignancies in AIDS patients in our country and see if some benign neoplasia would come into contact with HIV infection. For comparison, we used the prevalence of malignant neoplasia in other studies of HIV positive patients and for the benign neoplasia we used the prevalence among the general population, since we didn't find studies describing benign tumors associated with HIV infection. We also compared the frequency of neoplasms before and after the introduction of highly active antiretroviral therapy (HAART).
MATERIAL AND METHODS
This was a retrospective study on necropsies performed on HIV positive patients at the University Hospital in Uberaba, Minas Gerais, Brazil, between January 1989 and December 2008. Over this period, 1,785 necropsies were carried out, of which 261 (14.6%) were on patients who had been found to be serologically positive for HIV. There were no cases of the congenital transmission of HIV.
The neoplasias were described in relation to the benign or malignant type, sex and age of the patients. The cases were separated in two groups according to the date of necropsy if before or after the introduction of HAART (before or after 1997 in Uberaba, respectively), in order to assess whether there had been any increase or decrease in the number of neoplasia occurrences with the use of this medication.
We revised slides of all the tumors; usually slides are done from every organ including the uterine cervix in all necropsies; we microscopically analyzed the penis when injuries appeared on the macroscopy view. The classification of the tumors were done on a histological basis and when necessary with immunohistochemical analyses (leukocyte common antigen, CD20, CD3, desmin, actin 1A4, Myo D1, myogenin, CD38, CD79a, Kappa, Lambda, cytokeratin AE1/AE3, epithelial membrane antigen, carcinoembryonic antigen, HMB-45 and protein S-100).
The data relating to neoplasia frequencies before and after the introduction of HAART were analyzed using the X 2 test or Fisher's exact test. The mean ages in the total HIV group and HIV with neoplasia group were compared using Student's t-test or Mann-Whitney test. Differences were taken to be significant when the p-value was less than 0.05. The procedures in the present study were in accordance with and approved by the local committee of ethics in research.
RESULTS
Out of the 261 necropsies performed on HIV positive patients, 191 (73.2%) were male. The mean age was 35.3 ± 10.7 years, ranging from 16 to 69 years. Neoplasias were found in 58 (22.2%) of the 261 necropsies. Table 1 presents benign and malignant neoplasias in relation to age and sex. There tended to be a common occurrence of patients with neoplasms which were older than the total HIV group (p = 0.0176), females with neoplasms older than the female HIV group (p = 0.0221) and of female patients with malignant neoplasms which were older than females with benign neoplasms (p = 0.0493).
In the 58 HIV patients with neoplasia, 66 tumors were detected, of which 39 were benign, 21 malignant and six intraepithelial [one cervical intraepithelial neoplasia (CIN) grade I, two CIN II, one in situ carcinoma of glans and two condylomas of the penis]. Eight patients had two neoplasms: two patients with two benign neoplasias and six with one benign and one malignant neoplasia. Tables 2 and 3 summarize the data relating to the benign type and malignant neoplasias observed, distributed by gender and age. There were 39 benign neoplasms in 37 patients, the most frequent being 11 hepatic hemangiomas (10 men and one woman) and 11 uterine leiomyomas.
Malignant neoplasm was responsible for the death of 18 (6.9%) out of 261 total HIV positive patients. The neoplasms relating to death were: six KS, four NHL, one HL, one multiple myeloma, two gastric adenocarcinoma, one embryonic carcinoma, one hepatocellular carcinoma, one intestinal adenocarcinoma and one malignant testicular teratoma. Five of these 18 patients had HIV without signs of AIDS: one 54-year-old woman with HL, one 26-year-old man with embryonic carcinoma, one 52-year-old man with gastric adenocarcinoma, one 47-year-old woman with intestinal adenocarcinoma and one 26-year-old man with malignant testicular teratoma.
The neoplasms classically considered to be related to AIDS were: four cases of primary diffuse large B-cell NHL of the CNS; three men aged 16, 32 and 48-years-old and one woman aged 41-years-old. NHL was not diagnosed in any of the four patients before their deaths. Three other lymphoid neoplasias were seen: one HL, one plasmablastic plasmacytoma and one multiple myeloma. Six cases of KS with injuries spread amongst several organs; all of these patients were male, with ages ranging from 24 to 61-years-old; three had histories of bi/homosexual activity; five involved the digestive tract and only two involved the skin. There were no cases of invasive carcinoma of the uterine cervix. However, three precursor injuries were found: one CIN I in a 27-year-old patient and two CIN II in a 21 and 28-year-old patient.
Tables 4 and 5 present the frequencies of neoplasms according to whether it occurred before or after HAART (introduced in our university hospital in 1997). Although a greater number of neoplasms occurred in the period after the introduction of HAART (1997 to 2008) with a greater number of KS and lymphoid neoplasms, these differences were not statistically significant. We also compared the number of patients with and without benign and malignant neoplasias before and after HAART (Tables 6 and 7 ), but it was not significant.
DISCUSSION
Most of the studies evaluating necropsies on HIV-positive patients involved fewer than 100 necropsias and have described greater frequencies of infections than neoplasia. The frequency of neoplasia has ranged from 3.3% 12 to 28.9%
20
. We found a relatively high frequency of benign and malignant neoplasias (22.2% together) in the present study, but if we took into consideration only malignant neoplasias, it's just 8%.
The total of 261 HIV patients in our study had a mean age of 35.3 ± 10.7 years, and 73.2% were male. Comparisons with other Brazilian studies showed that similar mean ages were found: 33.3 years 7 and 34.8 years 12 . Studies carried out in developed countries presented mean ages slightly greater, of around 38 years 20, 24, 28 . This may be because of better adherence to treatment, better medical care and longer survival rates. For patients with neoplasms, in particular, there is a tendency for older ages as in our study 20, 28 . With regards to gender, there are greater numbers of males as found in our study 7, 12, 20 .
The neoplasias most frequently found were benign and not related to HIV or AIDS until now: hepatic hemangioma (4.2% of HIV patients) and uterine leiomyoma (15.7% of HIV-positive women). We did not find papers evaluating the frequency of benign neoplasms in patients with AIDS or HIV infection, but both neoplasms are frequently found among the general population, and their frequencies were within the expected range 14, 25 . Following these, the next most frequent tumors were lymphoid neoplasias and KS (2.7% and 2.3%, respectively). There are studies showing greater prevalence of lymphoid tumors 7, 12, 20, 27 and others presenting greater frequency of KS 1, 19, 24, 28 among HIV-positive patients. In our study, these frequencies were similar, as shown by other authors 23, 32 . In Brazil, BORGES et al. 7 described a frequency of KS that was similar to ours (1.9%), while CURY et al. 12 did not have any cases of this neoplasia. On the other hand, studies in developed countries have generally found higher frequencies of KS, such as KLATT et al. 24 , with KS occurring in 24.7% out of 565 necropsies on AIDS patients, and MASLIAH et al. 28 , with KS occurring in 27.1% out of 390 necropsies on HIV-positive individuals.
We found seven cases of lymphoid tumors (2.7% of total HIV); there were four NHL (1.5%), all primary of CNS. Studies in the United States and Europe have presented greater frequencies of NHL than found in Brazilian and African studies. HOFMAN et al. 20 in France, MARKOWITZ et al. 27 in the United States and RIDOLFO et al. 32 in Italy described frequencies of NHL of 14%, 9.1% and 16.5%, respectively. On the other hand, studies carried out in Africa have described frequencies of NHL that were closer to ours, although slightly higher, such as LUCAS et al. 26 with 2.8% and ANSARI et al. 1 with 3%. In Brazil, studies have described frequencies of NHL that are lower than in the United States and Europe, but higher than we found. BORGES et al. 7 observed a general frequency of lymphoma of 5.8%, consisting of one HL, one pleomorphic large T-cell NHL and one centroblastic/centrocytic NHL. The four cases of NHL that we described were diffuse large B-cell NHL; three others lymphoid neoplasias were seen: one HL, one plasmablastic plasmacytoma and one multiple myeloma. CURY et al. 12 found two NHL and one HL among 92 cases of AIDS (3.3% of lymphoma). We agree with LUCAS et al. 26 that the difference observed between developed and underdeveloped countries in relation to the frequency of neoplasia among AIDS patients is associated both with opportunistic infections occurring more frequently and the shorter survival rate among patients in underdeveloped countries.
In an earlier study in which we analyzed the cervicovaginal cytological changes in HIV-positive patients 29 , we found a higher frequency of Human Papillomavirus (HPV) infection and low-grade intraepithelial squamous injuries in the HIV-positive patients than in the HIV-negative patients. However, no such difference was observed in relation to high-grade injuries and invasive carcinoma. In the present study, the frequency of injuries of the uterine cervix was low: only one CIN I and two CIN II, and no cases of invasive carcinoma. Other large series of autopsies on AIDS patients have also not described any cases of invasive carcinoma of the uterine cervix 20, 24, 27 .
As shown in Table 3 , we found other malignant neoplasias than those classically described as associated with AIDS. Other authors have also found it 20, 24, 27 , however, they have concluded that these neoplasias were within the expected ranges for that age group among the general population. In our study, neoplasias not associated to AIDS until now, both benign and malignant, were within the expected range for the age group, except for two malignant neoplasias: one diffuse gastric adenocarcinoma in a 29-year-old man and one multiple myeloma in a 28-year-old man. These two neoplasms usually are found in patients older than 50-years-old 14, 25 .
We compared the frequencies of neoplasia in HIV-positive patients 28 did not observe any change in the frequency of neoplasia occurrence among AIDS patients after the introduction of HAART. We also observed higher frequencies of benign neoplasias (16.2% versus 9.8%, respectively) and malignant neoplasias (9.5% versus 4.9%, respectively) after HAART, although it was not significant. It could be because of the small number of cases in each group; it is important to also note that we separated the groups according to the date of the necropsy, usually the same as the diagnosis of the tumor, for both malignant and benign neoplasms, but that could influence in the results.
We therefore conclude that the types of neoplasia most frequently found in necropsies on HIV-positive patients in our study were KS and NHL, which are considered to be associated with AIDS. Other frequently found neoplasia types, particularly hepatic hemangioma and uterine leiomyoma, did not appear to be associated with HIV infection, since they occurred at the same frequency as observed among the general population. Finally, the introduction of HAART into our environment does not appear, so far, to have increased the frequency of neoplasia among HIV-positive patients.
RESUMO

Neoplasias benignas e malignas em 261 necropsias de pacientes HIV positivos no período de 1989 a 2008
Tendo em vista que trabalhos sobre necropsias de AIDS analisam apenas neoplasias malignas e que ocorreram alterações após a terapia antiretroviral altamente eficaz (HAART), este estudo foi feito com objetivo de avaliar a frequência de neoplasias benignas e malignas nos períodos pré e pós-HAART. Estudo retrospectivo de 261 necropsias de HIV positivos entre 1989 e 2008 em Uberaba -Brasil. Foram encontradas 66 neoplasias (39 benignas, 21 malignas e seis lesões pré-invasivas) em 58 pacientes. As neoplasias malignas mais frequentes foram linfóides, em 2,7% (quatro linfomas não Hodgkin, um Hodgkin, um mieloma múltiplo e um plasmocitoma plasmoblástico) e, sarcoma de Kaposi, em 2,3% (seis casos). As benignas mais frequentes foram hemangiomas hepáticos em 11 (4,2%) dos 261 casos e leiomiomas uterinos em 11 (15,7%) das 70 mulheres. No período pré-HAART ocorreram oito (9,8%) neoplasias benignas e quatro (4,9%) malignas em 82 pacientes; no pós-HAART, 29 (16,2%) benignas e 17 (9,5%) malignas; entretanto, essas diferenças não foram estatisticamente significantes. Concluímos que a introdução da HAART em nossa região não parece ainda ter alterado a frequência de neoplasias em pacientes HIV.
